Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.

Podrobná bibliografie
Hlavní autoři:	Mehta, Z, Manley, S, Zimmett, P, Bottazzo, G, Cull, C, Holman, R, Turner, R, Grp, U
Médium:	Journal article
Vydáno:	1999

Podobné jednotky

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
Autor: Turner, R, a další
Vydáno: (1997)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Autor: Turner, R, a další
Vydáno: (1997)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
Autor: Davis, T, a další
Vydáno: (2005)

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
Autor: Clark, A, a další
Vydáno: (2005)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
Autor: Cull, C, a další
Vydáno: (1999)

Ethnic differences in diabetic nephropathy - The UKPDS
Autor: Stevens, R, a další
Vydáno: (1999)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Autor: Cull, C, a další
Vydáno: (2001)

α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals
Autor: Nicolai M. Doliba, a další
Vydáno: (2022-06-01)

Glutamic Acid Decarboxylase Autoantibodies-Related Encephalitis
Autor: J Gordon Millichap
Vydáno: (2011-09-01)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)
Autor: Horton, V, a další
Vydáno: (1999)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
Autor: Horton, V, a další
Vydáno: (1999)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
Autor: Turner, R, a další
Vydáno: (1998)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
Autor: Cull, C, a další
Vydáno: (2000)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
Autor: Turner, R, a další
Vydáno: (1999)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
Autor: Manley, SE, a další
Vydáno: (2000)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Autor: Matthews, DR, a další
Vydáno: (1998)

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function
Autor: Yuxiao Zhu, a další
Vydáno: (2020-04-01)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Autor: Turner, R, a další
Vydáno: (1991)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Autor: Turner, R, a další
Vydáno: (1999)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
Autor: Cull, C, a další
Vydáno: (1995)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
Autor: Adler, A, a další
Vydáno: (2000)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Autor: Cull, C, a další
Vydáno: (2004)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
Autor: Cull, C, a další
Vydáno: (1993)

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
Autor: Hiroshi Mitoma, a další
Vydáno: (2017-01-01)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Autor: Adler, A, a další
Vydáno: (2003)

Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.
Autor: Davis, T, a další
Vydáno: (2003)

Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
Autor: Chang, T, a další
Vydáno: (2013)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
Autor: Wright, A, a další
Vydáno: (1998)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
Autor: Stratton, I, a další
Vydáno: (2000)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Autor: Matthews, DR, a další
Vydáno: (1998)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
Autor: Levy, J, a další
Vydáno: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
Autor: Levy, J, a další
Vydáno: (1993)

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
Autor: Bottazzo, G, a další
Vydáno: (2005)

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Autor: Stagg, C, a další
Vydáno: (2010)

AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
Autor: N. V. Piven, a další
Vydáno: (2014-07-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
Autor: Abbas J Mohammed
Vydáno: (2019-06-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
Autor: Abbas J Mohammed
Vydáno: (2019-06-01)

Autoantibodies to JA2ic and to Phogrin increase the prediction for insulin requirement in patients with Type 2 Diabetes
Autor: Bosi, E, a další
Vydáno: (2001)

UKPDS: what was the question? UK Prospective Diabetes Study.
Autor: Turner, R, a další
Vydáno: (1999)

Autoantibodies to islet amyloid polypeptide in diabetes.
Autor: Clark, A, a další
Vydáno: (1991)